1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vapiprost

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with vapiprost in 6 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (vapiprost)	Trials (vapiprost)	Recent Studies (post-2010) (vapiprost)
9,156	187	552	129	17	2

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (83.33)	18.2507
2000's	1 (16.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duddridge, M; Harris, A; Hendrick, DJ; Palmer, JB; Stenton, SC; Walters, EH; Ward, C	1
Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ	1
Hirata, Y; Matsuno, H; Nakashima, M; Takiguchi, Y; Uematsu, T; Umemura, K; Wada, K	1
Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N	1
Alper, CM; Burckart, GJ; Diven, WF; Doyle, WJ; Evans, RW; Jaffe, R	1
Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R	1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vapiprost

Article	Year
The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20, Issue:3 Topics: Administration, Inhalation; Adult; Biphenyl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Heptanoic Acids; Humans; Lung; Male; Methacholine Compounds; Middle Aged; Platelet Activating Factor; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes; Time Factors; Vital Capacity	1990

Article

Year

The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20, Issue:3

Topics: Administration, Inhalation; Adult; Biphenyl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Heptanoic Acids; Humans; Lung; Male; Methacholine Compounds; Middle Aged; Platelet Activating Factor; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes; Time Factors; Vital Capacity

1990

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vapiprost

Article	Year
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovascular research, 1994, Volume: 28, Issue:11 Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine	1994
Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig. European journal of pharmacology, 1993, Feb-16, Volume: 231, Issue:3 Topics: Adenosine Diphosphate; Animals; Azepines; Biphenyl Compounds; Guinea Pigs; Heptanoic Acids; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Ticlopidine; Triazoles	1993
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. British journal of pharmacology, 1996, Volume: 118, Issue:4 Topics: Animals; Benzoquinones; Biphenyl Compounds; Cell Count; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Eicosanoids; Female; Heptanoic Acids; Hypotension; Indomethacin; Isoquinolines; Lipoxygenase Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Antagonists; Pyridinium Compounds; Tetrahydroisoquinolines; Vascular Resistance	1996
Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. The Annals of otology, rhinology, and laryngology, 1998, Volume: 107, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Biphenyl Compounds; Chinchilla; Dinoprostone; Ear, Middle; Fatty Acids, Nonesterified; Heptanoic Acids; Hydrolases; Leukotriene Antagonists; Leukotriene C4; Mucous Membrane; Otitis Media; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Propionates; Quinolines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane B2; Triazoles	1998
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Thrombosis and haemostasis, 2002, Volume: 87, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase	2002